Microalbuminuria in Diabetic Patients in the Bamenda Health District
Science Journal of Clinical Medicine
Volume 6, Issue 4, July 2017, Pages: 63-67
Received: Mar. 15, 2017; Accepted: Apr. 19, 2017; Published: Oct. 18, 2017
Views 1827      Downloads 89
Marie Ebob Agbortabot Bissong, Department of Medical Laboratory Sciences, University of Bamenda, Bambili, Cameroon; Department of Biological Sciences, North West University, Mafikeng, South Africa; Department of Biomedical Sciences, University of Bamenda, Bambili, Cameroon
Gerald Ngo Teke, Department of Biomedical Sciences, University of Bamenda, Bambili, Cameroon
Moses Samje, Department of Biomedical Sciences, University of Bamenda, Bambili, Cameroon
Harris Goneh, Department of Medical Laboratory Sciences, University of Bamenda, Bambili, Cameroon
Frank Eric Tatsing Foka, Department of Biological Sciences, North West University, Mafikeng, South Africa
Henri-Lucien Kamga, Department of Medical Laboratory Sciences, University of Bamenda, Bambili, Cameroon
Article Tools
Follow on us
Diabetic nephropathy (DN) is the most common cause of end stage renal disease (ESRD) and it accounts for one third of all patients requiring renal replacement therapy in Africa. Diabetic patients with microalbuminuria (MA) have an increased risk of progression to macroalbuminuria and later to ESRD. So detecting MA which is a marker of DN helps to alert the clinician to intervene at a time when future renal damage is still preventable. The main goal of this study was to determine the prevalence of MA in diabetic patients at the Bamenda Regional Hospital. This study was a prospective cross sectional study involving diabetic patients at the Bamenda Regional Hospital. A random (spot) or first morning urine specimen was collected and MA was measured by a semi quantitative dipstick method using the URS-14H urine test strips. The prevalence of MA in the present study was 34.6%, which is high but similar to the results of other studies done in sub-Saharan Africa. Although MA was more common (50%) in individuals with diabetes more than 16 years, a high proportion (42.85%) of patients with MA had a duration of diabetes of ≤ 5years. There was no significant difference in the occurrence of MA with respect to age, gender and duration of diabetes. This study showed a high prevalence of MA in the diabetic population presenting at the Bamenda Regional Hospital. Consequently, measures of glycemic control should be enhanced in this population to prevent the progression to macroalbuminuria and ESRD.
Microalbuminuria, Diabetes Mellitus, Diabetic Nephropathy, Prevalence, Biomarker
To cite this article
Marie Ebob Agbortabot Bissong, Gerald Ngo Teke, Moses Samje, Harris Goneh, Frank Eric Tatsing Foka, Henri-Lucien Kamga, Microalbuminuria in Diabetic Patients in the Bamenda Health District, Science Journal of Clinical Medicine. Vol. 6, No. 4, 2017, pp. 63-67. doi: 10.11648/j.sjcm.20170604.14
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
World Health Organization. 1999. “Diabetes and classification of diabetes mellitus, part 1”. pg 2
E. Loghmani, “Diabetes mellitus: type 1 and type 2” chapter 14 in, Stang, J. Story M (eds). Guidelines for Adolescent Nutrition Services (2005) pg167 assessed on 24-11-2015 URL:http://www.epi.umn.edu/let/pubs/adol_book.shtm
E. Sobngwi, J. C. Mbanya, E. N. Moukouri, K. B. Ngu “Microalbuminuria and retinopathy in a diabetic population of Cameroon” Diabetes Res. Clin. Pract, 1999, 44(3), 191-6.
B. Vujičić, T. Turk, Z. Crnčević-Orlić, G. Đorđević, S. Rački, “Diabetic Nephropathy” In Tech 2012. http://dx.doi.org/10.5772/50115. Accessed on 10/12/2015.
P. Bhoomika, H. A. Dadhania-Amit, A. D. Gauravi “Study of microalbuminuria in diabetes type 2 patients as a marker of morbidity”. IJBAR, 2012, 3(10), 763.
T. Zelmanovitz, A. F. Gerchman, P. S. Balthazar, C. S. Fúlvio, J. Thomazelli, D. Matos, L. H. Canani “Diabetic nephropathy. Diabetology & Metabolic Syndrome” 2009, 1(10). http://www.dmsjournal.com/content/1/1/10 accessed on 10/12/2015.
W. Sheldon, P. A. Tobe, D. McFarlane, M. Naimark “Microalbuminuria in diabetes mellitus”. CMAJ, 2002, 167 (5), 499-502.
D. Parchwani, S. P. Singh “Microalbuminuria in diabetes patients: Prevalence and putative risk factors” Nat. J. Com. Med, 2011, 2(1), 126.
A. Abdalkader, H. Faris Al Lami “Prevalence and determinants of microalbuminurea among type 2 diabetes mellitus patients, Baghdad, Iraq”. Saudi J. Kidney Dis. Transpl, 2013, 27, 348-55.
M. M. Lloyd, J. Kuyl, H. Van Jaarsveld “Evaluation of point of care test for detecting microalbuminuria in diabetic patients”. S. Afr. Fam. Pract, 2011, 53(3), 281-286
J. J. Noubiap, J. Naidoo, A. P. Kengne “Diabetic nephropathy in Africa: A systematic review”, World J. Diabetes, 2015, 10, 6(5). 759-773.
S. A. Khudhair “Prevalence of Microalbuminuria In Diabetic Patients In Al-Najaf City. Kufa” Med. Journal, 2009, 12(1), 462.
S. P. Choukem, E. Sobngwi, P. Boudou, L. S. Fetita, R. Porcher, I. Fidaa, B. Blondeau, P. Vexiau, F. Mauvais-Jarvis, F. Calvo J. F. “Gautier “β- and α-Cell Dysfunctions in Africans with Ketosis-Prone Atypical Diabetes During Near-Normoglycemic Remission” Diabetes Care, 2013, 36 (1), 118–123.
M. N. Elbagir, M. A. Eltom, H. Rosling, C. Berne “Glycaemic Control of Insulin-Dependent Diabetes Mellitus in Sudan: Influence of Insulin Shortage” Diabetes Res. Clin. Pract, 1995, 30 (1), 43–52.
B. A. Eghan Jr, M. T. Frempong and M. Adjei-Poku “Prevalence and predictors of microalbuminuria in patients with diabetes mellitus: a cross-sectional observational study in Kumasi, Ghana” Ethnicity & Disease, 2007, 7(1), 726-730.
K. Luthale, J. Joy, T. Hrafenkell, A. G. Zulfiqarali, V. Kåre “Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania”, BMC Nephrol, 2007, 8(2). http://www.biomedcentral.com/1471-2369/8/2.
S. Ghosh, I. Lyaruu, K. Yeates “Prevalence and factors associated with microalbuminuria in type 2 diabetic patients at a diabetes clinic in northern Tanzania”. Afr. J. Diabetes Med, 2012, 20(2), 43.
P. Khan, M. Khan, W. Khan, A. Aziz and A. Ahad “Relationship of Glycemic Control with Prevalence of Microalbuminuria in Diabetic Patients” Gomal J. Med. Sci, 2012, 10(2), 201-204.
M. Sigdel, N. Rajbhandari, S. Basnet, A. Nagila, P. Basnet, B. K. Tamrakar “Microalbuminuria amongtype 2 diabetes mellitus patients in Pokhara, Nepal” Nepal Med. Coll. J, 2008, 10, 242-5.
M. T. Pruijm, G. Madeline, W. F. Rieson, M. Burnier, P. Bovet “Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers” J. Hypertens, 2008, 26, 871-7.
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186